Thomas A. Zanardi

Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects

Wendy Halpern, Patrick B. Lappin, Thomas A. Zanardi et al. · Toxicological Sciences · 2006 · 148 citations

Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice

Rosie Z. Yu, Mark Graham, Noah Post et al. · Molecular Therapy — Nucleic Acids · 2016 · 89 citations · Full text

Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys

Rosie Z. Yu, Rudy Gunawan, Noah Post et al. · Nucleic Acid Therapeutics · 2016 · 73 citations

Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys

Colby S. Shemesh, Rosie Z. Yu, Hans Gaus et al. · Molecular Therapy — Nucleic Acids · 2016 · 56 citations · Full text

Pharmacodynamics and Subchronic Toxicity in Mice and Monkeys of ISIS 388626, a Second-Generation Antisense Oligonucleotide That Targets Human Sodium Glucose Cotransporter 2

Thomas A. Zanardi, Su-Cheol Han, Eun Ju Jeong et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 50 citations